Table 1.
Compounds that increase the levels of FYVE-RFP
| Name | % of control FYVE-RFP spot intensity per cell |
||
|---|---|---|---|
| 2 h | 4 h | 8 h | |
| Rapamycin | 164.93 ± 10.96 | 131.41 ± 26.64 | 152.35 ± 4.55 |
| Nigericin | 148.43 ± 5.17 | 145.40 ± 8.39 | 140.54 ± 18.21 |
| Wiskostatin | 267.90 ± 6.16 | 240.08 ± 4.26 | 131.93 ± 11.05 |
| Fluspiriline | 224.98 ± 16.90 | 142.15 ± 5.77 | 108.53 ± 6.07 |
| Niguldipine | 147.18 ± 25.39 | 148.26 ± 3.67 | 125.53 ± 2.84 |
| Trifluoperazine | 136.58 ± 15.74 | 111.52 ± 13.45 | 94.28 ± 2.87 |
| Nicardipine | 132.05 ± 19.93 | 112.51 ± 10.09 | 104.77 ± 31.63 |
| Penitrem A | 121.40 ± 12.66 | 87.41 ± 5.90 | 72.71 ± 5.57 |
The levels of FYVE-RFP were measured at 2, 4, and 8 h after the compound addition as described in Methods and expressed as a percentage of that of control DMSO-treated cells.